Last articles with

Muscarinic Antagonists

16.321 articles found

03/02/2010
Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli. (Muscarinic Antagonists)
American journal of obstetrics and gynecology
01/02/2010
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study. (Muscarinic Antagonists)
01/02/2010
Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report. (Muscarinic Antagonists)
01/02/2010
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations. (Muscarinic Antagonists)
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology
29/01/2010
Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor. (Muscarinic Antagonists)
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology
29/01/2010
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. (Muscarinic Antagonists)
Clinical pharmacology and therapeutics
28/01/2010
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. (Muscarinic Antagonists)
Oncogene
28/01/2010
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. (Muscarinic Antagonists)
Annals of the rheumatic diseases
28/01/2010
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? (Muscarinic Antagonists)
Annals of the rheumatic diseases
28/01/2010
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. (Muscarinic Antagonists)

Articles from other specialties:

Anaesthesiology, Neurosurgery, Vascular Surgery - Angiology, Immunology, Clinical Biochemistry, Clinical Neurophysiology, Intensive Care, Psychology, Neurology, Forensic and Legal Medicine, Haematology, Paediatrics